Navigating the Challenges in an Era of Opioid Deprescribing: Behavioral Strategies for Patient Engagement and Success

July 12, 2019

Loading Events
  • This event has passed.
Watch Now View Presentation Slides

Presenter(s): Beth Darnall, PhD, Stanford University School of Medicine, Palo Alto, CA; Aram Mardian, MD, Phoenix VAHCS, Phoenix, AZ

Target Audience: This activity was developed to meet the needs of Clinicians treating patients in pain.

Webinar description: The faculty will provide strategies to identify which patients could benefit from potential opioid deprescribing, and stratify them into 3 groups: patients who are engaged and open to tapering, patients who are resistant to tapering, and patients with opioid use disorder who may also require medication assisted therapy. The faculty will then equip clinicians with tools and behavioral strategies to facilitate a process that unfolds over several visits to move patients toward psychological and emotional readiness to engage in a taper trial. Key aspects of a collaborative patient-centered taper include patient education, setting expectations, individualizing a slow and flexible schedule, and providing patient support.

Educational objectives:

  • Apply strategies to determine which patients on opioid analgesic therapy might benefit from deprescribing.
  • Assess patient readiness to taper opioid analgesics (when opioid deprescribing is the goal).
  • Describe key behavioral strategies to help move patients along the pathway from resistance to readiness to engage with a tapering trial.
  • Distinguish between clinician behaviors and language that foster patient engagement versus those that foster separation or alienation.
  • Identify and address patient fears and negative expectations to enhance engagement during patient-centered opioid tapering and minimize nocebo effects.

Continuing education credits:
The American Academy of Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Academy of Pain Medicine designates this course for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity


July 12, 2019
3:00 pm - 4:00 pm
Event Category:


Beth Darnall, PhD, Stanford University School of Medicine, Palo Alto, CA; Aram Mardian, MD, Phoenix VAHCS, Phoenix, AZ
Time Zone